ArticleIndian pacing and electrophysiology journal
Dual-chamber leadless pacemaker implant via the RIJ after failed femoral vein implant in a 65-year-old patient with symptomatic bradycardia, with left IJ port and right-sided AV fistula.
Article in Indian pacing and electrophysiology journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSinus node dysfunction (SND) is a disorder defined by abnormal initiation and conduction of electrical signals from the sinoatrial node. The preferred first-line treatment for a patient with symptomatic SND is a permanent pacemaker implant. We describe the implantation of an Aveir dual-chamber leadless pacemaker through the right internal jugular vein in a 65-year-old female patient with inaccessible femoral veins and a chemotherapy port in the left internal jugular vein.
methodsA retrospective review was performed at the University of California at Davis of the dual-chamber leadless pacemaker (Aveir DR) procedure.
resultsA 65-year-old female with a history of chronic dialysis use and chemotherapy, with persistence of left internal jugular vein port, presented with symptomatic bradycardia. After a failed attempt at an outside institution, she presented for a dual-chamber leadless pacemaker implant at our institution. Via the right internal jugular vein, the Aveir VR was deployed with stable thresholds, impedance, and sensing into the ventricular septum, with a subsequent atrial device being deployed with stable thresholds, impedance, and sensing into the right atrial appendage. Follow-up at 8 days demonstrated a ventricular threshold of 0.75V at 0.2 ms, impedance of 440 Ohms, and sensing of 9.9 mV. Follow-up atrial threshold of 0.75V at 0.2 ms, impedance of 400 Ohms, and P wave sensing of 0.8 mV.
conclusionPlacement of the Aveir dual chamber leadless pacemaker is safe in an adult patient without any complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.